来自体质和软骨衍生的iPSCs中介细胞原体的混基因潜力是由它们的转录基因特征预测的
Nazir M Khan1,2, Thanh N Doan1,2, Jarred M Kaiser1,2
1Department of Orthopaedics, Emory University, Atlanta, GA 30329, USA.
Genes & diseases
|January 6, 2026
概括
诱导多能干细胞衍生中干细胞 (iMSCs) 为软骨再生提供了一个有前途的替代方案,与成年MSCs相比,它们表现出类似海氨酸的特征和独特的分子配置.
科学领域:
- 干细胞生物学 干细胞生物学
- 再生医学是一种再生医学.
- 软骨组织工程 软骨组织工程
背景情况:
- 介质细胞干细胞 (MSC) 对于再生疗法至关重要,但存在一些局限性,包括丰度低和衰老.
- 诱导多能干细胞衍生的MSCs (iMSCs) 是一种潜在的替代品,但它们与成人MSC相比的特征尚未完全理解.
研究的目的:
- 为了比较iMSCs与成年MSCs (骨髓和脂肪衍生的) 和非分化的chondrocytes的chondrogenic潜力和分子概况.
- 阐明调控iMSC体生成的分子机制,并确定细胞表征的潜在标记物.
主要方法:
- 在高密度颗粒培养中与TGFβ3处理的同基差异化.
- 基因表达的分析使用基因基因阵列,大量RNA测序和基因调控网络分析.
- 综合转录组和蛋白质组分析以识别新型细胞标记物.
主要成果:
- iMSCs成功地产生了具有最小缩的类软骨,与成年MSCs相比,在表型上有所不同.
- 基因调控网络分析发现EGF,FGFR,FLT1和HIFA是iMSC冠状体发生的关键枢纽基因.
- 通过SMAD2/3传递TGFβ3信号,抑制了iMSCs中的过度缩,而RNA测序揭示了iMSCs和成年MSCs之间的明显的转录组形状和信号通路.
- 发现了8种新的非经典CD标记物,用于MSC的表征.
结论:
- iMSCs代表了一个可行的,潜在的无限源 chondroprogenitors 软骨再生,表现出与成年MSCs不同的特征.
- 了解起源特定的分子差异对于优化基于MSC的疗法至关重要.
- 识别的新型标记物可能有助于区分iMSC和推进MSC的表征.
相关概念视频
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K


